What is the partnership?
The AstraZeneca Young Health Programme was co-founded with the children's rights organisation Plan International UK. It focuses on the prevention of non-communicable diseases, notably diabetes, heart and respiratory diseases, and cancers in youth. The partnership supports research into young people's health, supports young people in lobbying to achieve change at a local and global level, and runs prevention initiatives tailored to local need.
What did the company do?
AstraZeneca contributes its expertise to the programme, including local market knowledge, analytics, management and delivery, and advocacy support. There are 16 active programmes in countries including Vietnam, Myanmar, Mexico and Thailand, and local AstraZeneca colleagues provide support on the ground, such as getting local politicians and media involved.
Why did it win?
Since 2010 almost 5,000 AstraZeneca colleagues have volunteered more than 40,000 hours, from providing one-on-one mentoring in Sweden to delivering curriculums on air pollution in China. The programme has directly reached three million young people. A social return on investment analysis found an estimated social return of six to eight dollars for each dollar invested.
What did the judges say?
"This project invests directly in building the evidence base as a foundation for achieving a structural solution to a global problem through advocacy, while also undertaking some very practical activities," commented Mark Waddington, chief executive of Hope And Homes For Children.